Skip to main content
Incanthera plc logo

Incanthera plc — Investor Relations & Filings

Ticker · INC ISIN · GB00BGL7YW15 LEI · 2138002HEV4UFBOEXQ97 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 97 across all filing types
Latest filing 2024-04-17 Share Issue/Capital Cha…
Country GB United Kingdom
Listing Aquis Stock Exchange INC

About Incanthera plc

https://incanthera.com/

Incanthera plc is a therapeutics company specializing in the discovery and development of targeted solutions for dermatology and oncology. The company develops and applies sophisticated formulation and delivery technologies to create novel treatments. Its pipeline includes clinical-stage oncology assets intended for licensing to pharmaceutical partners. Incanthera has also commercialized its dermatological expertise through its direct-to-consumer skincare brand, Skin+CELL, which is designed to address unmet needs in the skincare market.

Recent filings

Filing Released Lang Actions
Further re: Exercise of Warrants
Share Issue/Capital Change Classification · 100% confidence The document is an RNS (Regulatory News Service) announcement from Incanthera PLC regarding the exercise of warrants and the subsequent issuance of new ordinary shares. It details the number of shares issued, the proceeds received, the application for admission to trading on the Aquis Stock Exchange, and the resulting change in total voting rights. This falls under the category of share issuance and capital changes.
2024-04-17 English
Exercise of Warrants
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Incanthera PLC regarding the exercise of warrants, which results in the issuance of new ordinary shares. This type of corporate action, involving the creation of new shares and subsequent admission to trading, falls under the category of share issues or capital changes. The document explicitly mentions the number of new shares, the exercise price, and the updated total voting rights, which are standard components of a 'Share Issue/Capital Change' (SHA) filing.
2024-04-09 English
Initiation of Analyst Research and IGTV Interview
Report Publication Announcement Classification · 100% confidence The document is a short announcement (RNS) from Incanthera PLC regarding the availability of analyst research and a TV interview on their website. It does not contain the actual research report or financial statements, but rather serves as a notification that these materials have been published and are accessible via provided links. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement.
2024-03-25 English
Commercial Update
Regulatory Filings Classification · 95% confidence The document is an official announcement from Incanthera PLC regarding a commercial update on their 'Skin + CELL' product line, including order volumes, revenue projections, and product expansion. It is distributed via the Regulatory News Service (RNS) of the London Stock Exchange. While it contains financial projections, it is a corporate announcement rather than a formal quarterly or annual financial report. It fits the definition of a Regulatory Filing (RNS) as it is a general corporate announcement regarding business operations and inside information.
2024-03-25 English
Grant of Options
Regulatory Filings Classification · 98% confidence The document is an RNS announcement from Incanthera plc regarding the 'Grant of Options' to directors and senior management. It includes a detailed table of option holders, exercise prices, and vesting conditions, followed by the mandatory PDMR (Person Discharging Managerial Responsibilities) notification form required under EU Market Abuse Regulation (MAR). While it involves directors, it is specifically a notification of a grant of options (a form of compensation/incentive) rather than a personal trade of existing shares by a director (which would be DIRS). Given the specific nature of the disclosure regarding management incentives and the PDMR notification format, it is classified as a Director's Dealing/Management transaction disclosure.
2024-02-22 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is a regulatory requirement for shareholders to disclose when their voting rights in a company cross specific thresholds. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2024-01-11 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.